Life Science and Diagnostic Tools Analyst Massaro holds a meeting with CEO Smith and CFO Sherman in Boston on June 12 hosted by BTIG.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEO:
- NeoGenomics price target lowered to $21 from $23 at BTIG
- Starbucks downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
- NeoGenomics assumed with a Buy at Craig-Hallum
- NeoGenomics price target lowered to $20 from $21 at TD Cowen
- NeoGenomics backs FY24 revenue view $650M-$660M, consensus $654.56M